Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · IEX Real-Time Price · USD
2.195
-0.035 (-1.57%)
Jul 22, 2024, 10:16 AM EDT - Market open
Protara Therapeutics Employees
As of December 31, 2023, Protara Therapeutics had 27 total employees, including 26 full-time and 1 part-time employees. The number of employees increased by 2 or 8.00% compared to the previous year.
Employees
27
Change (1Y)
2
Growth (1Y)
8.00%
Revenue / Employee
n/a
Profits / Employee
-$1,572,963
Market Cap
45.92M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27 | 2 | 8.00% |
Dec 31, 2022 | 25 | -6 | -19.35% |
Dec 31, 2021 | 31 | 4 | 14.81% |
Dec 31, 2020 | 27 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Apyx Medical | 252 |
Vicarious Surgical | 131 |
Carisma Therapeutics | 107 |
NextCure | 82 |
Kezar Life Sciences | 58 |
Elicio Therapeutics | 32 |
Matinas BioPharma Holdings | 32 |
Lantern Pharma | 21 |
TARA News
- 27 days ago - Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit - GlobeNewsWire
- 2 months ago - Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing - GlobeNewsWire
- 3 months ago - Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition - GlobeNewsWire
- 3 months ago - Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC - GlobeNewsWire
- 4 months ago - Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference - GlobeNewsWire